---

---

entities : Glaxosmithkline plc    crawled time : 11:00   

save search

---

Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial of Latozinemab in Individuals with Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
Published: 2023-10-27 (Crawled : 11:00) - globenewswire.com
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 13.76% | O: -0.7% H: 0.0% C: -2.46%
ALEC | $5.27 1.93% 63K |

Health Technology

| -2.08% | O: 0.76% H: 0.38% C: -3.57%
dementia trial

---

CureVac berichtet über Fortschritt im Verfahren der Verletzung geistigen Eigentums gegen BioNTech in Deutschland
Published: 2023-09-28 (Crawled : 11:00) - curevac.com
GLAXF | News | $20.305 630 |

Health Technology

| 10.09% | O: -3.04% H: 2.1% C: 2.1%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 9.58% | O: -0.94% H: 0.44% C: -0.95%
CVAC | $2.54 0.4% 350K |

Health Technology

| -64.42% | O: 2.53% H: 1.99% C: -10.84%

---

Mersana Therapeutics Announces Changes in Leadership
Published: 2023-09-06 (Crawled : 11:00) - globenewswire.com
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 17.45% | O: 0.12% H: 0.06% C: -0.55%
MRSN | $3.295 4.6% 870K |

Health Technology

| 176.32% | O: 0.0% H: 9.65% C: 7.89%
therapeutics

---

Amicus Therapeutics Appoints Simon Harford as Chief Financial Officer
Published: 2023-08-21 (Crawled : 11:00) - globenewswire.com
GLAXF | News | $20.305 630 |

Health Technology

| 19.41% | O: 0.0% H: 0.68% C: 0.68%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 17.75% | O: 0.26% H: 0.23% C: -0.03%
LLY | News | $741.37 1.37% 800K |

Health Technology

| 36.87% | O: 2.54% H: 0.0% C: 0.0%
FOLD F | $10.875 0.51% 600K |

Health Technology

| -15.0% | O: 0.71% H: 0.66% C: -1.56%
therapeutics financial simon

---

Inflammatory Bowel Disease Market to grow by USD 7,687.43 million from 2022 to 2027; The increasing demand for biologics and targeted therapies drives the market - Technavio
Published: 2023-08-16 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $20.305 630 |

Health Technology

| 20.4% | O: 5.46% H: 0.0% C: -2.87%
NVSEF | News | $95.11 490 |

Health Technology

| 10.07% | O: -0.67% H: 0.0% C: 0.0%
VTRS | News A | $11.365 1.02% 1.6M |

Health Technology

| 0.81% | O: -0.99% H: 1.45% C: 1.36%
NVS | News | $97.31 2.3% 2.3M |

Health Technology

| -7.62% | O: -0.2% H: 0.34% C: -0.26%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 15.12% | O: -0.77% H: 0.79% C: 0.17%
BAX | $40.965 1.4% 810K |

Health Technology

| -4.6% | O: -0.4% H: 0.73% C: -0.24%
ABBV | News | $170.19 1.37% 1.6M |

Health Technology

| 10.72% | O: 0.56% H: 0.0% C: 0.0%
ABT | News | $108.01 0.88% 1.2M |

Health Technology

| 1.11% | O: -1.36% H: 0.88% C: 0.07%
SNY | News | $47.5 0.74% 450K |

Health Technology

| -13.05% | O: -1.33% H: 0.0% C: 0.0%
disease market

---

GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine
Published: 2023-07-20 (Crawled : 11:00) - biospace.com/
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 15.35% | O: 1.19% H: 0.42% C: 0.25%
vaccine license grants

---

Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players- Technavio
Published: 2023-07-14 (Crawled : 11:00) - prnewswire.com
CSLLY | $89.17 54K |

n/a

| -1.89% | O: -0.54% H: 0.0% C: -1.4%
GLAXF | News | $20.305 630 |

Health Technology

| 15.01% | O: 0.0% H: 1.42% C: 0.96%
AZNCF | News | $138.73 3.7K |

Health Technology

| 3.84% | O: 6.03% H: -2.14% C: -2.14%
ALPMY | News | $9.53 690K |

Manufacturing

| -34.32% | O: 0.96% H: 0.0% C: -1.71%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 16.64% | O: 0.03% H: 0.2% C: -0.8%
ABT | News | $108.01 0.88% 1.2M |

Health Technology

| -0.62% | O: 0.24% H: 0.44% C: -0.06%
SNY | News | $47.5 0.74% 450K |

Health Technology

| -11.89% | O: 0.36% H: 0.0% C: 0.0%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 3.57% | O: 1.79% H: 0.0% C: -2.23%
pharma vaccine research market

---

CureVac veröffentlicht Finanzergebnisse für das erste Quartal 2023 und informiert über seine Geschäftsentwicklung
Published: 2023-05-30 (Crawled : 11:00) - curevac.com
GLAXF | News | $20.305 630 |

Health Technology

| 20.05% | O: -1.3% H: 0.36% C: 0.36%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 18.55% | O: 0.18% H: 0.0% C: -1.28%
CVAC | $2.54 0.4% 350K |

Health Technology

| -72.35% | O: 0.0% H: 1.64% C: -3.06%

---

CureVac gibt Entwicklungen im Patentrechtsstreit mit Pfizer/BioNTech bekannt
Published: 2023-05-19 (Crawled : 11:00) - curevac.com
GLAXF | News | $20.305 630 |

Health Technology

| 12.78% | O: -1.67% H: 1.53% C: 0.28%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 15.28% | O: -0.14% H: 1.45% C: 1.28%
CVAC | $2.54 0.4% 350K |

Health Technology

| -71.12% | O: 0.91% H: 4.53% C: 2.49%
BNTX | News | $88.24 0.26% 180K |

Health Technology

| -16.14% | O: 0.37% H: 1.96% C: 1.09%

---

Zentalis Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
Published: 2023-05-10 (Crawled : 11:00) - globenewswire.com
GLAXF | News | $20.305 630 |

Health Technology

| 10.33% | O: -1.66% H: 0.0% C: 0.0%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 11.36% | O: -0.03% H: 0.38% C: 0.25%
ZNTL | $12.95 -0.39% 93K |

Health Technology

| -43.01% | O: 2.59% H: 4.49% C: 4.23%
pharmaceuticals financial results

---

CureVac gibt Impfung des ersten Teilnehmers in kombinierter Phase 1/2-Studie für multivalente, modifizierte Grippe-Impfstoffkandidaten bekannt, entwickelt in Zusammenarbeit mit GSK
Published: 2023-05-08 (Crawled : 11:00) - curevac.com
GLAXF | News | $20.305 630 |

Health Technology

| 8.56% | O: 4.81% H: 0.0% C: -6.12%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 9.76% | O: 0.24% H: 0.3% C: -0.81%
CVAC | $2.54 0.4% 350K |

Health Technology

| -69.3% | O: 0.0% H: 4.98% C: 2.55%

---

CureVac veröffentlicht Finanzergebnisse für das vierte Quartal sowie das Gesamtjahr 2022 und informiert über seine Geschäftsentwicklung
Published: 2023-04-25 (Crawled : 11:00) - curevac.com
GLAXF | News | $20.305 630 |

Health Technology

| 11.23% | O: 0.22% H: 4.05% C: 4.05%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 10.75% | O: 1.64% H: 0.19% C: -0.91%
CVAC | $2.54 0.4% 350K |

Health Technology

| -67.06% | O: -1.3% H: 2.24% C: -4.35%

---

CureVac veröffentlicht am 25. April 2023 Finanzergebnisse des vierten Quartals sowie des Gesamtjahres 2022 und informiert über seine Geschäftsentwicklung
Published: 2023-04-18 (Crawled : 11:00) - curevac.com
GLAXF | News | $20.305 630 |

Health Technology

| 3.89% | O: -6.76% H: 3.18% C: 1.34%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 8.56% | O: -0.64% H: 0.23% C: -1.0%
CVAC | $2.54 0.4% 350K |

Health Technology

| -68.14% | O: 0.13% H: 1.13% C: 0.0%

---

United Kingdom Over The Counter (OTC) Drugs Markets, Competition Forecast & Opportunities, 2027: Generics, Investments and Expenses & Expanding Pharmaceutical Industry Promises Market Growth
Published: 2023-04-04 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $20.305 630 |

Health Technology

| 15.8% | O: 2.17% H: 0.0% C: 0.0%
AZNCF | News | $138.73 3.7K |

Health Technology

| 0.89% | O: 3.16% H: 0.0% C: -0.28%
PRGO | $30.475 1.38% 360K |

Health Technology

| -16.13% | O: 0.14% H: 0.08% C: -0.11%
JNJ | News | $150.09 0.65% 3.9M |

Health Technology

| -4.93% | O: 0.08% H: 1.27% C: 0.97%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 12.91% | O: 0.64% H: 1.11% C: 1.02%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 0.31% | O: 0.1% H: 0.84% C: 0.39%
investments growth market

---

Dermatitis Global Market Research Report 2023: An $8.57 Billion Market by 2027 - Long-term Forecasts to 2032
Published: 2023-03-20 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $20.305 630 |

Health Technology

| 20.62% | O: 1.07% H: 0.0% C: -0.06%
SNYNF | News | $92.7 600K |

Health Technology

| -2.49% | O: 0.98% H: 0.0% C: 0.0%
ALPMY | News | $9.53 690K |

Manufacturing

| -31.34% | O: -0.5% H: 1.38% C: 1.23%
NVS | News | $97.31 2.3% 2.3M |

Health Technology

| 15.31% | O: 0.78% H: 0.74% C: 0.72%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 19.14% | O: 1.38% H: 1.16% C: 1.13%
ABBV | News | $170.19 1.37% 1.6M |

Health Technology

| 8.86% | O: 0.19% H: 1.18% C: 1.04%
SNY | News | $47.5 0.74% 450K |

Health Technology

| -2.87% | O: 0.4% H: 0.0% C: 0.0%
report dermatitis research global market

---

Vitamin and Minerals Global Market Report 2023: A $24.69 Billion Industry by 2026 - Long-term Forecast to 2032
Published: 2023-02-24 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $20.305 630 |

Health Technology

| 16.73% | O: 1.61% H: 0.0% C: -0.4%
SNYNF | News | $92.7 600K |

Health Technology

| -4.53% | O: -2.11% H: 0.0% C: 0.0%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 15.12% | O: -1.13% H: 0.11% C: -0.83%
ABT | News | $108.01 0.88% 1.2M |

Health Technology

| 4.41% | O: -1.07% H: 0.34% C: -0.98%
SNY | News | $47.5 0.74% 450K |

Health Technology

| -2.62% | O: 0.72% H: 0.0% C: 0.0%
global report market

---

Blow Fill Seal Technology Global Market Report 2023: Growing Demand from the Food and Beverage Industry Bolsters Sector
Published: 2023-02-23 (Crawled : 11:00) - prnewswire.com
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 13.57% | O: -1.45% H: 0.57% C: 0.11%
CTLT | $55.97 -0.14% 790K |

Health Technology

| -17.16% | O: 0.35% H: 0.88% C: -0.37%
global report growing technology food market

---

Insights on the Pharmaceutical API Manufacturing Global Market to 2032: North America was the Largest Region in 2022
Published: 2023-02-22 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $20.305 630 |

Health Technology

| 14.04% | O: 0.48% H: 0.0% C: -2.77%
SNYNF | News | $92.7 600K |

Health Technology

| -1.38% | O: 0.53% H: 1.82% C: 1.82%
AZNCF | News | $138.73 3.7K |

Health Technology

| -1.27% | O: -0.48% H: 0.14% C: 0.14%
NVS | News | $97.31 2.3% 2.3M |

Health Technology

| 9.23% | O: 0.98% H: 0.03% C: -1.06%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 12.75% | O: 0.19% H: 0.0% C: -0.91%
LLY | News | $741.37 1.37% 800K |

Health Technology

| 123.3% | O: 0.37% H: 1.18% C: 0.11%
ALB | News | $114.52 1.99% 720K |

Process Industries

| -53.59% | O: 0.43% H: 1.9% C: 1.42%
ABBV | News | $170.19 1.37% 1.6M |

Health Technology

| 10.45% | O: -0.66% H: 0.76% C: -0.22%
SNY | News | $47.5 0.74% 450K |

Health Technology

| -3.05% | O: 0.54% H: 0.0% C: 0.0%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 0.78% | O: 0.04% H: 0.04% C: -1.11%
america global market

---

SpyBiotech Appoints Industry Veteran Eddie Gray as Chair of its Board of Directors
Published: 2023-02-13 (Crawled : 11:00) - biospace.com/
GLAXF | News | $20.305 630 |

Health Technology

| 11.72% | O: -1.73% H: 0.0% C: -1.43%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 13.25% | O: 0.61% H: 0.47% C: 0.47%

---

Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference
Published: 2023-01-24 (Crawled : 11:00) - nutriband.com
SNYNF | News | $92.7 600K |

Health Technology

| -5.89% | O: -0.27% H: 0.1% C: 0.1%
NTRB | $3.255 -8.05% 18K |

Manufacturing

| 0.85% | O: -2.85% H: 0.0% C: -1.76%
RANI | $6.61 -0.9% 68K |

| 4.87% | O: -1.1% H: 1.91% C: -3.82%
MRK | $126.99 0.04% 3.1M |

Health Technology

| 15.53% | O: 0.11% H: 0.0% C: -1.35%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 14.79% | O: -1.02% H: 0.0% C: -0.86%
SNY | News | $47.5 0.74% 450K |

Health Technology

| -5.27% | O: -0.72% H: 0.0% C: 0.0%
conference transdermal

---

Gainers vs Losers

87%

13%

Top 10 Gainers

MTTR | News M | $4.64 166.67% 18M |

AGBA | $2.61 108.8% 41M |

Finance

CZOO | $9.32 86.77% 18M |

EDBL | News | $6.7 78.19% 1.7M |

OPRT | News | $3.37 49.78% 8.9M |

Finance

MTC | $2.14 37.18% 4.9M |

Technology Services

VNRX | $0.8 33.33% 2.9M |

Health Technology

MLEC | $1.79 27.86% 2.6M |

n/a

PALI | $6.29 27.59% 22M |

Manufacturing

MCRB | $0.7902 26.51% 6.9M |

Health Technology

---

Your saved searches

---